Ranitidine, NDMA and the multidistrict litigation (MDL) in the US
This post is an attempt to provide a snapshot of the multidistrict litigation (MDL) in the US concerning ranitidine, marketed under the name of Zantac. Most of the information for this post comes from the 341 page ruling1 of December…